Conference item
CAMPATH-1H in inflammatory arthritis.
- Abstract:
- CAMPATH-1H is a humanised mAb directed against lymphocytes. This mAb has been used to treat patients with rheumatoid arthritis. Clinical improvement with reduction in the Ritchie index and joint score has lasted for up to 8 months in some patients. A profound and prolonged lymphopaenia is induced by the mAb, with CD4+ numbers remaining suppressed for up to one year.
- Publication status:
- Published
Actions
Authors
- Journal:
- Clinical and experimental rheumatology More from this journal
- Volume:
- 11 Suppl 8
- Pages:
- S165-S167
- Publication date:
- 1993-01-01
- Event title:
- 2ND INTERNATIONAL SYMP ON THE IMMUNOTHERAPY OF THE RHEUMATIC DISEASES ( PREPRINTS )
- ISSN:
-
0392-856X
- Keywords:
- Pubs id:
-
pubs:28383
- UUID:
-
uuid:7de70dc9-63dd-4b28-a640-5f87ee6d206c
- Local pid:
-
pubs:28383
- Source identifiers:
-
28383
- Deposit date:
-
2012-12-19
Terms of use
- Copyright date:
- 1993
If you are the owner of this record, you can report an update to it here: Report update to this record